Summary:
MARVEL CLINICAL RESEARCH is seeking volunteers for a clinical trial for a vaccine to prevent RSV, a major cause of lung infection in people ages 60 and above. Help in the effort to protect our community from this common, yet highly contagious virus, and potentially gain protection yourself.
WHAT IS RSV?
Respiratory Syncytial Virus (RSV) is a viral infection of the lungs and respiratory tract that is highly contagious, typically spreading through airborne droplets when someone coughs or sneezes or via contact with surfaces on which it can survive for hours. Each year, RSV affects an estimated 64 million people and leads to 160,000 deaths, with most of the severe cases occurring in older adults.
Qualified Participants Must:
• 60 and Older
•
Proficient with smartphone device
•
No previous RSV vaccine
Qualified Participants May Receive:
Earn up to $1000 through the course of 12 months